Benzyl 2,4-dichloro-5,7-dihydro-6H-pyrrolo[3,4-d]pyrimidine-6-carboxylate, 97%, 1g

Ethyl 5-tert-butylisoxazole-3-carboxylate, 95.0%, 10g

Methyl 3-hydroxymethyl-1-methyl-1H-pyrazole-5-carboxylate, 95.0%, 250mg

Thieno[3,2-b]thiophene-2,5-dicarbaldehyde, 95.0%, 1g

Cinchonidine Sulfate Dihydrate>98.0%(T)25g

tert-butyl 4-(1H-pyrazol-5-yl)piperidine-1-carboxylate, 97%, 250mg

[1,1':4',1'':4'',1'''-Quaterphenyl]-3,3''',5,5'''-tetracarbaldehyde, 97%, 250mg

GC-Kapillarsäule ROTI®Cap-1, unpolar, L 50 m, Ø-Innen 0,32 mm, Filmd. 0,35 µm, 1 Stück

2-((Dimethylamino)methyl)benzonitrile, 97%, 5g

2-Hydroxy-6-isopropyl-3-methylbenzaldehyde, 98%, 250mg

(4R,4'R)-4,4'-DIISOBUTYL-4,4',5,5'-TETRAHYDRO-2,2'-BIOXAZOLE, 95%, 250mg

1-(6-chloro-3-pyridazinyl)-4-piperidinamine dihydrochloride hydrate, 95.0%, 1g

2-Hydroxy-4-pentadecylbenzoic acid, 250mg